CAD and seminoma: Interestingly, the analysis showed a highly significant lower level of E-CAD in seminoma samples compared to nonseminoma samples (Figure 5A), supporting the role of nuclear PTTG1 in driving E-CAD transcriptional repression in human seminomas.